Particle Data Platform

GLP‑1s Aren’t The Solution

9:4010:15 · 35s

Ashley Koff argues GLP‑1 agonists are not standalone fixes—even in dysfunction—calling them enablers for a personalized plan, not the solution.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.